T1	PROC 46 67	Estudio a largo plazo
T2	PROC 76 87	seguimiento
#1	AnnotatorNotes T2	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T3	DISO 112 146	infectados con hepatitis C crónica
T4	CHEM 389 399	interferón
#2	AnnotatorNotes T4	C0021747; Interferons; Amino Acid, Peptide, or Protein · Immunologic Factor
T5	PROC 175 186	tratamiento
#3	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	PROC 193 207	ensayo clínico
#4	AnnotatorNotes T6	C0008976; Clinical Trials; Research Activity
T7	DISO 267 275	cirrosis
#5	AnnotatorNotes T7	C1623038; Cirrhosis; Disease or Syndrome
T8	PROC 337 348	tratamiento
#6	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	CHEM 374 384	sofosbuvir
#7	AnnotatorNotes T9	C2976303; sofosbuvir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T10	DISO 408 441	infección por hepatitis C crónica
T11	DISO 498 509	Hepatitis C
#8	AnnotatorNotes T11	C0019196; Hepatitis C; Disease or Syndrome
T12	DISO 536 576	Infección por el virus de la hepatitis C
T13	PROC 653 689	consentimiento informado por escrito
#9	AnnotatorNotes T13	C0811741; Obtain informed written consent; Health Care Activity
T14	CHEM 809 819	sofosbuvir
#10	AnnotatorNotes T14	C2976303; sofosbuvir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T15	CHEM 929 932	SOF
#11	AnnotatorNotes T15	C2976303; sofosbuvir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T16	PROC 949 964	estudio clínico
#12	AnnotatorNotes T16	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T17	PROC 1055 1066	tratamiento
#13	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	CHEM 824 834	interferón
#14	AnnotatorNotes T18	C0021747; Interferons; Amino Acid, Peptide, or Protein · Immunologic Factor
T19	PROC 1204 1213	protocolo
#15	AnnotatorNotes T19	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T20	PROC 1217 1228	tratamiento
#16	AnnotatorNotes T20	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T21	CHEM 1323 1326	SOF
#17	AnnotatorNotes T21	C2976303; sofosbuvir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T22	PROC 1343 1358	estudio clínico
#18	AnnotatorNotes T22	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T23	CHEM 1397 1400	ARN
#19	AnnotatorNotes T23	C0035668; RNA; Nucleic Acid, Nucleoside, or Nucleotide
T24	PROC 1508 1519	tratamiento
#20	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	DISO 1529 1546	cirrosis hepática
#21	AnnotatorNotes T25	C0023890; Liver Cirrhosis; Disease or Syndrome
T26	PROC 1572 1581	protocolo
#22	AnnotatorNotes T26	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T27	PROC 1585 1596	tratamiento
#23	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	PROC 1625 1645	trasplante de hígado
#24	AnnotatorNotes T28	C0023911; Transplantation of liver; Therapeutic or Preventive Procedure
T29	CHEM 1768 1771	SOF
#25	AnnotatorNotes T29	C2976303; sofosbuvir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T30	PROC 1788 1803	estudio clínico
#26	AnnotatorNotes T30	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T31	PROC 1821 1835	diagnosticados
#27	AnnotatorNotes T31	C0011900; Diagnosis; Diagnostic Procedure
T32	DISO 1839 1847	cirrosis
#28	AnnotatorNotes T32	C1623038; Cirrhosis; Disease or Syndrome
T33	PROC 1868 1879	tratamiento
#29	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T34	PROC 2010 2021	tratamiento
#30	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	DISO 2030 2033	VHC
#31	AnnotatorNotes T35	C0019196; Hepatitis C; Disease or Syndrome
T36	CHEM 2082 2113	agente en fase de investigación
#32	AnnotatorNotes T36	C0013230; Investigational New Drugs; Pharmacologic Substance
T37	CHEM 1680 1683	SOF
#33	AnnotatorNotes T37	C2976303; sofosbuvir; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T38	DISO 2144 2154	enfermedad
#34	AnnotatorNotes T38	C0012634; Disease; Disease or Syndrome
T39	DISO 2202 2218	trastorno médico
T40	PROC 2261 2272	seguimiento
#35	AnnotatorNotes T40	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T41	PROC 2289 2301	evaluaciones
#36	AnnotatorNotes T41	C1261322; Evaluation procedure; Health Care Activity
T42	PROC 2324 2333	protocolo
#37	AnnotatorNotes T42	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T43	DISO 101 111	cirróticos
#38	AnnotatorNotes T43	C1623038; Cirrhosis; Disease or Syndrome
T44	PROC 356 363	régimen
#39	AnnotatorNotes T44	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T45	DISO 741 744	VHC
#40	AnnotatorNotes T45	C0019196; Hepatitis C; Disease or Syndrome
T46	PROC 786 793	régimen
#41	AnnotatorNotes T46	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T47	PROC 895 918	régimen totalmente oral
T48	PROC 1010 1017	régimen
#42	AnnotatorNotes T48	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T49	PROC 1289 1312	régimen totalmente oral
T50	PROC 1397 1408	ARN del VHC
#43	AnnotatorNotes T50	C1272251; Hepatitis C virus RNA assay; Laboratory Procedure
T51	ANAT 1538 1546	hepática
#44	AnnotatorNotes T51	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T52	ANAT 1639 1645	hígado
#45	AnnotatorNotes T52	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T53	PROC 1668 1675	régimen
#46	AnnotatorNotes T53	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T54	PROC 1734 1757	régimen totalmente oral
T55	DISO 1884 1887	VHC
#47	AnnotatorNotes T55	C0019196; Hepatitis C; Disease or Syndrome
T56	Date 13 17	2014
T57	Date 54 67	a largo plazo
T58	LIVB 91 100	pacientes
#48	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	Duration 139 146	crónica
#49	AnnotatorNotes T59	C0205191; chronic; Temporal Concept
T60	LIVB 255 262	sujetos
#50	AnnotatorNotes T60	C0681850; Study Subject; Group
T61	Neg_cue 385 388	sin
T62	Duration 434 441	crónica
#51	AnnotatorNotes T62	C0205191; chronic; Temporal Concept
T63	LIVB 553 576	virus de la hepatitis C
#52	AnnotatorNotes T63	C0220847; hepatitis C virus; Virus
T65	Neg_cue 820 823	sin
T66	Route 914 918	oral
#53	AnnotatorNotes T66	C1527415; Oral Route of Drug administration; Functional Concept
T67	LIVB 972 979	sujetos
#54	AnnotatorNotes T67	C0681850; Study Subject; Group
T68	LIVB 1242 1249	sujetos
#55	AnnotatorNotes T68	C0681850; Study Subject; Group
T69	Route 1308 1312	oral
#56	AnnotatorNotes T69	C1527415; Oral Route of Drug administration; Functional Concept
T70	LIVB 1405 1408	VHC
#57	AnnotatorNotes T70	C0220847; hepatitis C virus; Virus
T71	Duration 1451 1477	aproximadamente 12 semanas
T72	CONC 1492 1504	última dosis
T73	Neg_cue 1600 1602	no
T74	LIVB 1687 1694	sujetos
#58	AnnotatorNotes T74	C0681850; Study Subject; Group
T75	Route 1753 1757	oral
#59	AnnotatorNotes T75	C1527415; Oral Route of Drug administration; Functional Concept
T77	LIVB 1921 1927	sujeto
#60	AnnotatorNotes T77	C0681850; Study Subject; Group
T80	LIVB 2277 2283	sujeto
#61	AnnotatorNotes T80	C0681850; Study Subject; Group
A1	Assertion T4 Negated
A2	Assertion T18 Negated
A3	Assertion T28 Negated
A4	Status T46 History_of
A5	Status T14 History_of
A6	Status T18 History_of
A7	Status T47 History_of
A8	Status T15 History_of
A9	Status T17 History_of
A10	Status T49 History_of
A11	Status T21 History_of
A12	Status T28 History_of
A13	Status T53 History_of
A14	Status T37 History_of
A15	Status T54 History_of
A16	Status T29 History_of
A17	Status T38 History_of
A18	Status T39 History_of
A19	Status T48 History_of
#62	AnnotatorNotes T57	C0443252; Long-term; Temporal Concept
#63	AnnotatorNotes T1	C0023981; Longitudinal Studies; Research Activity 
#64	AnnotatorNotes T3	C0524910; Hepatitis C, Chronic; Disease or Syndrome 
#65	AnnotatorNotes T10	C0524910; Hepatitis C, Chronic; Disease or Syndrome
#66	AnnotatorNotes T12	C0524910; Hepatitis C, Chronic; Disease or Syndrome
T64	Spec_cue 2234 2242	pudieran
T76	CONC 2243 2253	interferir
A20	Assertion T76 Speculated
#67	AnnotatorNotes T76	C0521102; Interferes with; Functional Concept
R1	Negation Arg1:T61 Arg2:T4	
R2	Negation Arg1:T65 Arg2:T18	
R3	Negation Arg1:T73 Arg2:T28	
R4	Speculation Arg1:T64 Arg2:T76	
R5	Overlap Arg1:T1 Arg2:T57	
T78	Observation 1176 1179	RVS
#68	AnnotatorNotes T78	C3888663; Sustained viral response; Finding
T79	Observation 1103 1106	RVS
#69	AnnotatorNotes T79	C3888663; Sustained viral response; Finding
T81	Observation 1376 1379	RVS
#70	AnnotatorNotes T81	C3888663; Sustained viral response; Finding
R6	Experiences Arg1:T58 Arg2:T43	
R7	Overlap Arg1:T43 Arg2:T3	
R8	Experiences Arg1:T58 Arg2:T3	
R9	Has_Duration_or_Interval Arg1:T3 Arg2:T59	
T82	Observation 160 166	curado
A21	Status T82 History_of
R10	After Arg1:T82 Arg2:T5	
R11	After Arg1:T82 Arg2:T6	
R12	Experiences Arg1:T58 Arg2:T82	
R13	Before Arg1:T43 Arg2:T82	
R14	After Arg1:T2 Arg2:T5	
R15	After Arg1:T2 Arg2:T6	
R16	Experiences Arg1:T60 Arg2:T7	
T83	Observation 294 324	respuesta virológica sostenida
#71	AnnotatorNotes T83	C3888663; Sustained viral response; Finding
R17	Experiences Arg1:T60 Arg2:T83	
R18	After Arg1:T83 Arg2:T8	
R19	After Arg1:T83 Arg2:T44	
R20	Used_for Arg1:T9 Arg2:T8	
R21	Used_for Arg1:T9 Arg2:T44	
R22	Experiences Arg1:T60 Arg2:T8	
R23	Experiences Arg1:T60 Arg2:T44	
R24	Experiences Arg1:T60 Arg2:T4	
R25	Experiences Arg1:T60 Arg2:T10	
R26	Has_Duration_or_Interval Arg1:T10 Arg2:T62	
R27	Overlap Arg1:T7 Arg2:T10	
R28	Causes Arg1:T63 Arg2:T12	
T84	Observation 610 617	capaces
#72	AnnotatorNotes T84	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
T85	Observation 623 639	estar dispuestos
#73	AnnotatorNotes T85	C0600109; Willing; Finding
R29	Overlap Arg1:T84 Arg2:T13	
R30	Overlap Arg1:T85 Arg2:T13	
T86	Observation 700 737	participado previamente en un estudio
A22	Status T86 History_of
#74	AnnotatorNotes T86	C1278516; Patient participation status; Finding (?)
R31	Used_for Arg1:T14 Arg2:T46	
R32	Has_Route_or_Mode Arg1:T15 Arg2:T66	
R33	Used_for Arg1:T15 Arg2:T47	
R34	Experiences Arg1:T67 Arg2:T48	
R35	Experiences Arg1:T67 Arg2:T79	
R36	Experiences Arg1:T67 Arg2:T17	
T87	CONC 992 1005	documentación
R37	Overlap Arg1:T78 Arg2:T20	
R38	Overlap Arg1:T48 Arg2:T79	
R39	Overlap Arg1:T17 Arg2:T79	
R40	Experiences Arg1:T68 Arg2:T78	
R41	Experiences Arg1:T68 Arg2:T20	
R42	Experiences Arg1:T68 Arg2:T49	
R43	Has_Route_or_Mode Arg1:T21 Arg2:T69	
R44	Used_for Arg1:T21 Arg2:T49	
R45	Experiences Arg1:T68 Arg2:T81	
R46	Overlap Arg1:T20 Arg2:T81	
R47	Overlap Arg1:T49 Arg2:T81	
T88	Result_or_Value 1409 1450	< LIC (límite inferior de cuantificación)
R48	Has_Result_or_Value Arg1:T50 Arg2:T88	
R49	Experiences Arg1:T68 Arg2:T50	
R50	Overlap Arg1:T81 Arg2:T50	
R51	Overlap Arg1:T50 Arg2:T71	
R52	Has_Duration_or_Interval Arg1:T81 Arg2:T71	
R54	After Arg1:T81 Arg2:T72	
R56	Used_for Arg1:T21 Arg2:T24	
R57	Has_Dose_or_Strength Arg1:T21 Arg2:T72	
R55	Location_of Arg1:T51 Arg2:T25	
R58	Location_of Arg1:T52 Arg2:T28	
R59	After Arg1:T28 Arg2:T53	
R60	Used_for Arg1:T37 Arg2:T53	
R61	Experiences Arg1:T74 Arg2:T54	
R62	Used_for Arg1:T29 Arg2:T54	
R63	Has_Route_or_Mode Arg1:T29 Arg2:T75	
R64	Experiences Arg1:T74 Arg2:T32	
R65	Before Arg1:T32 Arg2:T33	
R66	Before Arg1:T31 Arg2:T33	
R67	Experiences Arg1:T74 Arg2:T55	
R68	Overlap Arg1:T32 Arg2:T55	
T89	Quantifier_or_Qualifier 1934 1942	previsto
#75	AnnotatorNotes T89	C1301732; Planned; Functional Concept
R69	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T89	
T90	Quantifier_or_Qualifier 1995 2006	nuevo curso
R70	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T90	
R71	Experiences Arg1:T77 Arg2:T34	
R72	Experiences Arg1:T77 Arg2:T35	
R73	Experiences Arg1:T77 Arg2:T36	
T91	Quantifier_or_Qualifier 2155 2181	clínicamente significativa
A23	Status T91 History_of
R74	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T91	
#76	AnnotatorNotes T39	C0012634; Disease; Disease or Syndrome
T92	Quantifier_or_Qualifier 2219 2229	importante
#77	AnnotatorNotes T92	C3898777; Important; Qualitative Concept
A24	Status T92 History_of
R77	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T92	
R78	Experiences Arg1:T80 Arg2:T38	
R79	Experiences Arg1:T80 Arg2:T39	
R80	Experiences Arg1:T80 Arg2:T41	
R81	Before Arg1:T38 Arg2:T40	
R82	Before Arg1:T39 Arg2:T40	
T93	Observation 2307 2333	cumplimiento del protocolo
#78	AnnotatorNotes T93	C2364172; Adherence To Medication Regime; Finding
R85	Before Arg1:T38 Arg2:T93	
R86	Before Arg1:T39 Arg2:T93	
#79	AnnotatorNotes T87	C0920316; Documentation; Intellectual Product
T94	CONC 1019 1035	fechas de inicio
T95	CONC 1019 1028;1038 1066	fechas de finalización del tratamiento
R87	Experiences Arg1:T74 Arg2:T25	
R88	Experiences Arg1:T74 Arg2:T27	
R89	Experiences Arg1:T74 Arg2:T28	
R90	Experiences Arg1:T74 Arg2:T53	
#80	AnnotatorNotes T91	C5209294; Clinical relevance; Intellectual Product
R91	Experiences Arg1:T58 Arg2:T5	
R53	Experiences Arg1:T74 Arg2:T33	
R92	Used_for Arg1:T36 Arg2:T34	
#81	AnnotatorNotes R57	(?)
#82	AnnotatorNotes T72	C1762893; Date last dose; Temporal Concept
#83	AnnotatorNotes T94	C0808070; Start Date; Temporal Concept
#84	AnnotatorNotes T95	C3173313; End date of treatment or therapy; Temporal Concept
#85	AnnotatorNotes T82	C0679252; cure of disease; Finding | C0438113; Patient condition resolved; Finding
A25	Status T34 Future
A26	Status T36 Future
A27	Experiencer T77 Patient
A28	Experiencer T58 Patient
A29	Experiencer T60 Patient
A30	Experiencer T67 Patient
A31	Experiencer T68 Patient
A32	Experiencer T74 Patient
A33	Experiencer T80 Patient
